PropertyValue
?:definition
  • Point-of-care whole blood analyzers designed primarily to detect abnormalities in the components required to complete normal blood clotting. Most analyzers perform at least one or more of the following assays on whole blood: activated clotting time (ACT), activated partial thromboplastin time (WBAPTT), prothrombin time (WBPTT), recalcification time (WBRT), heparin dose response, heparin/protamine titration, and high-dose thrombin time (HiTT).These analyzers use photometric, mechanical impedance, or electromagnetic techniques (or sometimes combinations of techniques) to assess the coagulation process. Whole blood point-of-care coagulation analyzers are used to detect clotting deficiencies and to monitor the effects of drugs (e.g., heparin) and of blood component therapy.
?:hasCUIAnnotation
?:hasGeneratedBy
?:type

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/C0180001_UMD>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/C0180001_UMD>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all